伟思医疗
(688580)
| 流通市值：20.27亿 | | | 总市值：20.27亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 191,578,926.4 | 87,670,336.46 | 462,223,134.18 | 331,773,648.23 |
| 营业收入 | 191,578,926.4 | 87,670,336.46 | 462,223,134.18 | 331,773,648.23 |
| 二、营业总成本 | 154,659,278.69 | 72,378,521.4 | 347,039,683.14 | 246,108,828.76 |
| 营业成本 | 56,299,944.17 | 26,139,839.8 | 130,514,365.89 | 94,802,776 |
| 税金及附加 | 2,635,903.41 | 1,278,310.74 | 5,725,398.05 | 4,015,919.53 |
| 销售费用 | 50,300,484.1 | 22,218,305.11 | 123,635,441.34 | 87,545,469.2 |
| 管理费用 | 24,142,713.93 | 12,722,391.99 | 47,491,101.06 | 33,094,086.46 |
| 研发费用 | 28,731,566.97 | 15,427,799.83 | 57,654,199.29 | 41,705,282.25 |
| 财务费用 | -7,451,333.89 | -5,408,126.07 | -17,980,822.49 | -15,054,704.68 |
| 其中:利息费用 | 643,716.3 | 321,858.15 | 1,318,536.24 | 1,004,032.98 |
| 其中:利息收入 | 8,113,856.31 | 5,709,147.07 | 19,315,486.55 | 16,068,908.05 |
| 加:公允价值变动收益 | - | - | -964,049.74 | - |
| 加:投资收益 | 5,003,107.97 | 1,133,776.46 | 10,579,946.08 | 7,142,555.58 |
| 资产处置收益 | 434.96 | - | -2,113.24 | 3,814.14 |
| 信用减值损失(新) | -139,747.28 | -11,288.86 | -2,188,349.52 | -263,357.56 |
| 其他收益 | 11,074,992.37 | 6,209,111.81 | 25,833,405.17 | 18,986,844.55 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 52,858,435.73 | 22,623,414.47 | 148,442,289.79 | 111,534,676.18 |
| 加:营业外收入 | 118,008.57 | 102,047.79 | 1,611,693.02 | 695,776.51 |
| 减:营业外支出 | 28,529.64 | - | 42,293.84 | 45,254.79 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 52,947,914.66 | 22,725,462.26 | 150,011,688.97 | 112,185,197.9 |
| 减:所得税费用 | 3,327,508.5 | 972,308.93 | 13,753,059.95 | 10,504,094.93 |
| 六、净利润 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 | 101,681,102.97 |
| 持续经营净利润 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 | 101,681,102.97 |
| 归属于母公司股东的净利润 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 | 101,681,102.97 |
| (一)基本每股收益 | 0.52 | 0.32 | 2 | 1.49 |
| (二)稀释每股收益 | 0.52 | 0.32 | 1.99 | 1.49 |
| 九、综合收益总额 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 | 101,681,102.97 |
| 归属于母公司股东的综合收益总额 | 49,620,406.16 | 21,753,153.33 | 136,258,629.02 | 101,681,102.97 |
| 公告日期 | 2024-08-29 | 2024-04-26 | 2024-04-26 | 2023-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |